BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25676557)

  • 1. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective.
    Ra SH; Su A; Li X; Zhou J; Cochran AJ; Kulkarni RP; Binder SW
    Mod Pathol; 2015 Jun; 28(6):799-806. PubMed ID: 25676557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous Cell Carcinoma Arising From Keratoacanthoma: An Evaluation by RT-PCR.
    Ni C; Su A; Ra S; Li X; Cochran A; Binder S
    Am J Dermatopathol; 2016 Mar; 38(3):247-9. PubMed ID: 26067455
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin.
    Ra SH; Li X; Binder S
    Mod Pathol; 2011 Jul; 24(7):963-73. PubMed ID: 21743436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus DNA in nonanogenital keratoacanthoma and squamous cell carcinoma of patients with HIV infection.
    Payne D; Newman C; Tyring S
    J Am Acad Dermatol; 1995 Dec; 33(6):1047-9. PubMed ID: 7490352
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA image cytometry of keratoacanthoma and squamous cell carcinoma.
    Herzberg AJ; Kerns BJ; Pollack SV; Kinney RB
    J Invest Dermatol; 1991 Sep; 97(3):495-500. PubMed ID: 1875048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?
    Corominas M; Kamino H; Leon J; Pellicer A
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6372-6. PubMed ID: 2668964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
    Lee YS; Teh M
    Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma: Update on the Debate.
    Nirenberg A; Steinman H; Dixon A
    Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
    Putti TC; Teh M; Lee YS
    Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous proliferations on the legs of women: Qualitative examination of histopathology, TP53 sequencing, and implications for diagnosis in a series of 30 cases.
    Ko CJ; Glusac EJ; McNiff JM; Rodic N; Leffell DJ
    J Am Acad Dermatol; 2017 Dec; 77(6):1126-1132.e1. PubMed ID: 28709693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin.
    Vahlquist A; Andersson E; Coble BI; Rollman O; Törmä H
    J Invest Dermatol; 1996 May; 106(5):1070-4. PubMed ID: 8618041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
    Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
    Majores M; Bierhoff E
    Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly enriched pathways and differentially expressed genes distinguishing cutaneous squamous cell carcinoma from pseudoepitheliomatous hyperplasia.
    Ra SH; Su A; Li X; Binder S
    Diagn Mol Pathol; 2013 Mar; 22(1):41-7. PubMed ID: 23370431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the mitochondrial microsatellite instability of Keratoacanthoma and cutaneous squamous cell carcinoma.
    Alam MR; Alsulimani A; Haque S; Jung HR; Lee JH; Jeon CH; Kim DK
    Cancer Genet; 2021 Aug; 256-257():115-121. PubMed ID: 34111657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.
    Waring AJ; Takata M; Rehman I; Rees JL
    Br J Cancer; 1996 Mar; 73(5):649-53. PubMed ID: 8605102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A flow cytometric study of the DNA content from paraffin-embedded samples of keratoacanthoma and squamous cell carcinoma].
    Hashimoto Y; Matsuo S; Iizuka H
    Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):701-5. PubMed ID: 1942578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoglein in multiple self-healing squamous epithelioma of Ferguson-Smith--comparison of staining patterns with actinic keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Hunter JA; Clark RE
    Arch Dermatol Res; 1998 Jun; 290(6):319-24. PubMed ID: 9705163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.